Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

PubMed

Artificial Intelligence in Health Insurance: An Interagency Framework for Federal and State Oversight.

PMID: 42878516 ·

R, e, n, e, e, , S, i, r, b, u

JournalThe Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics
Year
PMID42878516

Abstract

Despite mounting enthusiasm regarding the introduction of artificial intelligence (AI) software as a medical device (SaMD) to clinical care and, consequently, the development of a new regulatory proposal for the federal oversight of AI/machine learning medical devices, little attention has been paid to the oversight of AI tools used by large insurers. The US Food and Drug Administration (FDA) has advanced an "Action Plan" for clinical AI governance. However, the unregulated application of insura

Official Source

View on PubMed →

Data sourced from PubMed / NCBI. For the full text and most current information, always refer to the official record.

↑